Efficacy and Safety of a Low-Dose 21-Day Combined Oral Contraceptive Containing Ethinylestradiol 20μg and Drospirenone 3mg

被引：0

作者：

D. Cibula

U. Karck

H. G. Weidenhammer

J. Kunz

S. Alincic

J. Marr

机构：

[1] Charles University,Department of Obstetrics and Gynaecology, General Faculty Hospital

[2] University of Freiburg,Department of Obstetrics and Gynaecology

[3] Klarastr,undefined

[4] Hospital Zollikerberg,undefined

[5] Schering AG,undefined

[6] MDG G&A,undefined

来源：

Clinical Drug Investigation | 2006年 / 26卷

关键词：

Combine Oral Contraceptive; Contraceptive Efficacy; Drospirenone; Withdrawal Bleeding; Normal Menstruation;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Objective: The purpose of this study was to assess the efficacy and safety of a new low-dose oral contraceptive containing ethinylestradiol 20μg and drospirenone 3mg (EE 20μg/drsp 3mg).

引用

页码：143 / 150

页数：7

共 50 条

[31] The influence of a low-dose oral contraceptive containing 20 mu g ethinylestradiol and 75 mu g gestodene on lipid and carbohydrate metabolism and hemostasis
Winkler, UH
Gaspard, U
Leidenberger, F
NEW OPTION IN LOW-DOSE ORAL CONTRACEPTION - EXPANDING THE GESTODENE CHOICE, 1996, : 49 - 63
[32] Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen
Mansour, Diana
Verhoeven, Carole
Sommer, Werner
Weisberg, Edith
Taneepanichskul, Surasak
Melis, Gian Benedetto
Sundstrom-Poromaa, Inger
Korver, Tjeerd
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2011, 16 (06): : 430 - 443
[33] Sexual behavior of women taking low-dose oral contraceptive containing 15 μg ethinylestradiol/60 μg gestodene
Caruso, S
Agnello, C
Intelisano, G
Farina, M
Di Mari, L
Cianci, A
CONTRACEPTION, 2004, 69 (03) : 237 - 240
[34] Effect of a combined oral contraceptive containing 3 mg of drospirenone and 30 μg of ethinyl estradiol on the human endometrium
Lüdicke, F
Johannisson, E
Helmerhorst, FM
Campana, A
Foidart, JM
Heithecker, R
FERTILITY AND STERILITY, 2001, 76 (01) : 102 - 107
[35] Contraceptive efficacy of a combined oral contraceptive containing ethinyloestradiol 20 μg/drospirenone 3 mg administered in a 24/4 regimen: a pooled analysis of four open-label studies
Anttila, Leena
Bachmann, Gloria
Hernadi, Laszlo
Kunz, Michael
Marr, Joachim
Klipping, Christine
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2011, 155 (02) : 180 - 182
[36] Three years' clinical experience with a new low-dose oral contraceptive containing 20 mu g ethinylestradiol and 75 mu g gestodene: Efficacy, cycle control and tolerability
Dusterberg, B
Ellman, H
Muller, U
Rowe, E
Muhe, B
NEW OPTION IN LOW-DOSE ORAL CONTRACEPTION - EXPANDING THE GESTODENE CHOICE, 1996, : 21 - 35
[37] Prospective study on sexual behavior of women using 30 μg ethinylestradiol and 3 mg drospirenone oral contraceptive
Caruso, S
Agnello, C
Intelisano, G
Farina, M
Di Mari, L
Sparacino, L
Cianci, A
CONTRACEPTION, 2005, 72 (01) : 19 - 23
[38] Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20μg ethinylestradiol/100 μg levonorgestrel and 20 μg ethinylestradiol/500 μg norethisterone
Endrikat, J
Hite, R
Bannemerschult, R
Gerlinger, C
Schmidt, W
CONTRACEPTION, 2001, 64 (01) : 3 - 10
[39] User Satisfaction with the Combined Oral Contraceptive Drospirenone 3 mg/Ethinylestradiol 20 μg (Yasminelle®) in Clinical Practice A Multi-Country, Questionnaire-Based Study
Short, Mary
CLINICAL DRUG INVESTIGATION, 2009, 29 (03) : 153 - 159
[40] User Satisfaction with the Combined Oral Contraceptive Drospirenone 3 mg/Ethinylestradiol 20 μg (Yasminelle®) in Clinical PracticeA Multi-Country, Questionnaire-Based Study
Mary Short
Clinical Drug Investigation, 2009, 29 : 153 - 159

← 1 2 3 4 5 →